A carregar...
CK1δ as a potential therapeutic target to treat bladder cancer
Bladder cancer is the second most common genitourinary malignancy in the world. However, only immune-checkpoint inhibitors and erdafitinib are available to treat advanced bladder cancer. Our previous study reported that 4-((4-(4-ethylpiperazin-1-yl) phenyl)amino)-N-(3,4,5-trichlorophenyl)-7H-pyrrolo...
Na minha lista:
| Publicado no: | Aging (Albany NY) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7185098/ https://ncbi.nlm.nih.gov/pubmed/32282334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102966 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|